Antimicrobial susceptibility of Pseudomonas aeruginosa isolates from dogs with otitis externa
Authors:
Open Access
- 30 July 2011
- journal article
- Published by Wiley in Veterinary Record
- Vol. 169 (5) , 125
Abstract
Pseudomonas aeruginosa is a common cause of otitis externa in dogs, and treatment of these infections is becoming problematic because of the increasing number of multiresistant strains. The aim of the present study was to compare the in vitro activities of cefepime, ceftazidime, enrofloxacin, ciprofloxacin, gentamicin and ticarcillin/clavulanic acid against 104 strains of P aeruginosa isolated from dogs with otitis externa. Antimicrobial susceptibility and minimum inhibitory concentrations, in µg/ml, were evaluated by the E test (bioMérieux). The most active compound was ceftazidime, with 100 per cent efficiency. The majority of tested strains were susceptible to ticarcillin/clavulanic acid (89.4 per cent), followed by ciprofloxacin (88.5 per cent) and cefepime (60.6 per cent). The highest resistance was observed to enrofloxacin (51.9 per cent) and gentamicin (43.3 per cent). Large numbers of strains were intermediately susceptible to antibiotics registered for use in veterinary medicine in Croatia – enrofloxacin (47.1 per cent) and gentamicin (41.3 per cent).Keywords
This publication has 17 references indexed in Scilit:
- Antimicrobial resistance and genetic characterization of fluoroquinolone resistance of Pseudomonas aeruginosa isolated from canine infectionsVeterinary Microbiology, 2008
- Resistance Mechanisms of Multiresistant Pseudomonas aeruginosa Strains from Germany and Correlation with HypermutationAntimicrobial Agents and Chemotherapy, 2007
- Occurrence of antimicrobial resistance in bacteria from diagnostic samples from dogsJournal of Antimicrobial Chemotherapy, 2007
- Susceptibility of Pseudomonas aeruginosa to antimicrobials: a 2004 French multicentre hospital studyJournal of Antimicrobial Chemotherapy, 2007
- Antimicrobial Testing of Selected Fluoroquinolones Against Pseudomonas aeruginosa Isolated From Canine OtitisJournal of the American Animal Hospital Association, 2007
- Involvement of the MexXY-OprM Efflux System in Emergence of Cefepime Resistance in Clinical Strains of Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2006
- Spread of efflux pump-overexpressing, non-metallo-β-lactamase-producing, meropenem-resistant but ceftazidime-susceptible Pseudomonas aeruginosa in a region with blaVIM endemicityJournal of Antimicrobial Chemotherapy, 2005
- Clinical Strains of Pseudomonas aeruginosa Overproducing MexAB-OprM and MexXY Efflux Pumps SimultaneouslyAntimicrobial Agents and Chemotherapy, 2004
- Oxacillinase-Mediated Resistance to Cefepime and Susceptibility to Ceftazidime inPseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2001
- Resistance Mechanisms inPseudomonas aeruginosaand Other Nonfermentative Gram‐Negative BacteriaClinical Infectious Diseases, 1998